X4 Pharmaceuticals' Series A Round

X4 Pharmaceuticals raised a round of funding on August 28, 2015.

X4 Pharmaceuticals is a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment of refractory solid tumors. The company will deliver game-chang…

Articles about X4 Pharmaceuticals' Series A Round: